Better syringes for people who inject drugs
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study provides safer, low-dead-space syringes to people who inject drugs to help reduce the spread of infections like HIV and hepatitis C. It is designed for people in low- and middle-income countries who use needle exchange programs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older (16 or older in some countries).
- You have injected drugs at least once in the past month.
- You get your needles and syringes from a needle exchange program (at a clinic, mobile service, or outreach).
- You understand and speak the local language.
- If you think you are HIV or hepatitis C negative, you are willing to get tested for both.
- You agree to be part of the study and give your permission (informed consent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether making needle and syringe programs easier to use helps more people in prison get clean needles. It's about reducing infection risks for everyone at the participating prisons.
This study tests how well a program combining telemedicine (virtual doctor visits) and peer support can help prevent HIV among people who inject drugs. You'd get trained, attend weekly group sessions, and invite a friend or partner to also take part.
This study tests a rapid-start antiretroviral therapy (ART) approach for people who inject drugs and have HIV. The goal is to see if starting HIV medicine quickly helps reduce stigma and improve health outcomes.
This trial trains people who use drugs to talk with friends in their social network about HIV testing and services. It aims to encourage more people to get tested and linked to care.
This study aims to make hepatitis C treatment simpler and more accessible for people who inject drugs. If you join, you'll receive care that fits your lifestyle and helps cure hep C.
This study works with syringe service programs to see if offering opt-out HIV and hepatitis C testing helps more people get screened and connected to care. It focuses on programs that do not already offer this testing and are in high-need areas.
Hear when a new Drug Use trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.